Sine oculis homeobox 1 (Six1) is a homeodomain transcription factor that is aberrantly expressed in a variety of human cancers, including colorectal cancer (CRC).
Six1 has been reported to play a key role in the proliferation and migration of CRC cells but the underlying molecular mechanisms are still poorly characterized. In the present study, we found that Six1 overexpression promoted the proliferation and 
K E Y W O R D S
β-catenin, colorectal cancer, migration, proliferation, Six1 auditory system and certain sensory organs. 3 Six1 was also found to be highly expressed and implicated in both tumor initiation and tumor progression in a variety of human cancers, including breast cancer, 4 Hodgkin lymphoma, 5 cervical cancer, 6 osteosarcoma, 7 hepatocellular carcinoma, 8, 9 colorectal cancer, [10] [11] [12] ovarian cancer, 13, 14 rhabdomyosarcoma, 15 and Wilms tumors. 16 As a DNA-specific transcription factor, Six1 has no intrinsic transcriptional activation domain and requires EYA1 to initiate target gene expression, whereas in the absence of EYA1, SIX1 associates with corepressor DACH1 to inhibit transcription of target genes. 2 It has been documented that Six1 induces the Warburg effect (or aerobic glycolysis) which facilitates breast tumor growth with elevated glucose uptake and lactate production in vitro and in vivo by directly upregulating the expression of many glycolytic genes depending on interaction with histone acetyltransferases HBO1 and AIB1. 17 In addition, Six1 promotes tumor progression in mouse models of breast cancer through facilitation of lymphangiogenesis,
EMT by upregulating vascular endothelial growth factor C (VEGF-C) and activating ERK and TGF-β signaling. 18, 19 When compared to normal mucosa, Six1 is highly expressed in 50% of CRC tissues and was associated with poor prognosis in two large cohorts (total n = 945).
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In CRC cells, Six1 KD with shRNA significantly reduced proliferative potential, migratory ability and invasiveness of colorectal cancer cells. 20 Six1 also boosts EMT of CRC cells by suppressing E-cadherin expression partly through repression of miR-200-family expression and activation of ZEB1. 21 This evidence provides strong support for the involvement of Six1 in CRC progression, but the molecular mechanisms remain largely unknown. 
| Plasmids and siRNA knockdown
Full-length cDNA of the Six1 gene was synthesized by Sangon F I G U R E 2 Sine oculis homeobox 1 (Six1) knockdown (KD) inhibits proliferation and migration of LoVo cells in vitro. A, siSix1 or siCtrl constructs were transfected into LoVo cells, and Six1 expression was assessed by western blot. β-Actin was used as a loading control. B, Cell proliferation was determined using the MTT assay. Cell motility was assessed using the wound-healing assay (C,D) and the Transwell cell migration assay (E,F). Results are from three independent experiments, and expressed as mean ± SD. *P < .05, **P < . 01, vs control group Three sequences specific to human Six1 were selected to generate siRNA, target 1: GCA CAA GAA CGA GAG CGU ATT; target 2: 
| Western blotting
Cells ( 
| Fractionation of nuclear and cytoplasmic proteins
Cytoplasmic proteins and the nuclear proteins were extracted using 
| Wound-healing assay
LoVo cells or HCT116 cells treated appropriately were seeded into 60-mm dishes and cultured at 37°C until 90% confluent. 
| In vitro migration assays
Human CRC cell migration was evaluated using a Transwell assay system. Briefly, LoVo and HCT116 cells suspended in 100 μL serumfree media were seeded into the upper compartment of each chamber of a 24-well plate (with an 8-μm pore size insert; BD Biosciences, San Jose, CA, USA). RPMI-1640 (600 μL) containing 10% FBS was added into the lower chamber to serve as a chemoattractant. After incubation for 24 hours, cells on the upper surface of the membrane were removed with a cotton swab and cells migrating to the lower compartment of the insert were fixed and stained using a 0.5% crystal violet solution for 45 minutes and were then counted under a microscope. This experiment was conducted in triplicate.
| Statistical analysis
All data are expressed as mean ± SD. Experimental results were analyzed with GraphPad Prism Software Version 5.0 (GraphPad Software Inc., La Jolla, CA, USA). P < .05 was considered to be statistically significant.
F I G U R E 4 β-Catenin knockdown (KD) blocked sine oculis homeobox 1 (Six1)-mediated proliferation and migration of colorectal cancer (CRC) cells. A, siβ-Catenin or siCtrl constructs were transfected into HCT116-Six1 cells, and β-catenin expression was assessed by western blot. β-Actin was used as a cytoplasmic loading control and LaminB1 was used as a nuclear loading control. Cell proliferation and migration were evaluated by MTT assays (B), wound-healing assay (C,D), and Transwell migration assay (E,F). Results are from three independent experiments and expressed as mean ± SD. **P < .01, ***P < .001 vs control group.
| RE SULTS

| Sine oculis homeobox 1 overexpression promotes proliferation and migration of HCT116 cells
To determine the role of Six1 in the progression of CRC, we first 
| Sine oculis homeobox 1 knockdown decreases proliferation and migration of LoVo cells
To 
| Sine oculis homeobox 1 induces activation of Wnt/β-catenin signaling
To determine the signaling pathways involved in Six1-mediated progression of CRC, we screened multiple potential signaling pathways that had been reported to regulate the progression of CRC. We found that the Wnt/β-catenin pathway was activated in response to Six1 levels. However, no obvious difference could be observed for many other signaling pathways, such as JNK, p53, AKT, P38 and AMPK pathways. Specifically, we found that Six1 overexpression in HCT116 cells led to a redistribution of β-catenin from the cytoplasm to the nucleus, driving an increase in the nuclear accumulation of β-catenin ( Figure 3 and Figure S2A ). Consistent with this finding, Six1 knockdown by siRNA reduced Wnt activation ( Figure 3 and Figure S2B ).
Additionally, cyclin D1, a crucial downstream effector in the Wnt/β-catenin signaling pathway, was also upregulated or downregulated as a response to the activation or inhibition of Wnt pathway, as shown in Figure 3 . This suggests that Six1 facilitates activation of the Wnt/β-catenin signaling pathway in colorectal cancer cells. Importantly, total β-catenin levels were almost unchanged in HCT116 and LoVo cells in all conditions, indicating that nuclear localization rather than altered expression mediates these observed effects.
| Wnt/β-catenin signaling is involved in Six1-mediated CRC progression
We next silenced β-catenin expression in Six1-overexpressing cells with a commercial β-catenin siRNA ( Figure 4A ). Interestingly, this F I G U R E 6 Wnt signaling activator, LiCl, restored the impaired proliferation and migration of sine oculis homeobox 1 (Six1) knockdown (KD) cells. A, LoVo cells transfected with Six1 siRNA were incubated with 10 mmol/L LiCl for 24 h, and β-catenin expression was assessed by western blot. β-Actin was used as a cytoplasmic loading control and LaminB1 was used as a nuclear loading control. Cell proliferation and migration were evaluated by MTT assays (B), woundhealing assay (C,D), and Transwell migration assay (E,F). Results from three independent experiments are expressed as mean ± SD. **P < .01, ***P < .001 vs control group.
β-catenin silencing significantly reduced Six1-mediated proliferation and migration of these CRC cells relative to control cells ( Figure 4B) . 
| D ISCUSS I ON
Colorectal cancer is the third most frequently diagnosed malignancy and the fourth most frequent cause of cancer death worldwide. 28 CRC is a heterogeneous disease at the molecular level. Extensive heterogeneity of CRC confers its resistance to targeted treatments. 29 CRC incidence has been increasing in developing countries, especially in Western Asia and Eastern Europe. 30 Thus, further study to determine the molecular mechanism underlying CRC progression is urgently required. In our study, we found that Six1 is involved in the proliferation and migration of human CRC cells through activating the Wnt/β-catenin signaling pathway. Our results may give rise to a new target for intervention in the treatment of CRC and may improve the future treatment of CRC.
Six1, a member of the sine oculis homeobox family proteins, is a transcription factor 31 and has been reported to be involved in tumorigenesis. 3 For example, Six1 overexpression can promote tumor growth and metastasis in breast cancer by amplifying TGF-β signaling. 32 In addition, SIX1 enhanced cell proliferative and migratory potential and suppressed cell apoptosis by activating the PI3K/AKT signaling pathway through reducing phosphatase and tensin homolog (PTEN) expression in osteosarcoma cells. and Wnt/β-catenin signaling in the progression of CRC, we will investigate the exact mechanism underlying Six1 regulating β-catenin nuclear localization which might serve as an attractive target for the molecular therapy of CRC.
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